Cancer Letters
Volume 208, Issue 1 , Pages 43-49, 10 May 2004

Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma

Department of Surgery, Division of Surgical Oncology, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan

Abstract 

Although increased dietary fat or cholesterol has been reported to be a risk factor for the development of certain cancers, the effect of the serum lipid level on tumor metastasis has not been well documented. Fasting serum levels of total cholesterol (TC) and triglycerides (TG) were examined in 54 patients with superficial esophageal cancer (SEC) invading lamia musucularis or submucosal layer who underwent esophagectomy with classical lymphadenectomy. The association between lymph node metastasis and the preoperative serum lipid levels as well as the pathological findings was retrospectively analyzed. The levels of TC and TG were significantly higher in 18 node-positive than in 36 node-negative patients (TC: 205.4±38.9 vs. 174.5±26.8 mg/dl, P<0.01; TG: 152.0±68.5 vs. 88.7±28.6 mg/dl, P<0.001). Patients with hypercholesterolemia (TC≧220 mg/dl) and hypertriglyceridemia (TG≧150 mg/dl) showed extremely high rates of nodal metastasis (80 and 91%, respectively), that were significantly higher than those of patients with normal lipid levels (P<0.01 and P<0.001). When hyperlipidemia was defined as the presence of either hypertriglyceridemia or hypercholesterolemia, hyperlipidemia was an independent risk factor for nodal metastasis in SEC. Elevated serum lipid levels might bring favorable circumstances for the development of lymph node metastasis in the early stage of EC. Hyperlipidemia might prompt us to perform more studies to investigate possible metastasis.

Keywords:  Superficial esophageal cancer, Lymphatic metastasis, Hyperlipidemia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(03)00784-5

doi:10.1016/j.canlet.2003.11.010

Cancer Letters
Volume 208, Issue 1 , Pages 43-49, 10 May 2004